We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXLS:NASDAQExlService Holdings, Inc. Analysis

Data as of 2026-09-27 - not real-time

$34.75

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

ExlService Holdings, Inc. is priced at $34.75 and its moving averages line up in bullish order, the shorter sitting above the longer. It has lost 1.8% over the past 30 days. Momentum indicators put RSI at 44.8 (neutral) with MACD reading bearish. Price has been bracketed by support at $34.33 and resistance at $38.86.
The shares look undervalued, trading on 22.0 times earnings below a sector average of 34.7. The average analyst target implies 28.4% above today's level. Revenue is growing at 15.6% on a 11.2% profit margin.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 26.1%, a beta of 0.00 and a maximum drawdown of 42.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 7 out of 10.

Top Market Events

Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter.NEW YORK, Sept. 02, 2026 GLOBE NEWSWIRE -- ExlService Holdings, Inc. NASDAQ: EXLS , a global data and AI company,...ExlService Holdings stock closed at USD 35.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 33.19
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 22.0 versus sector average of 34.7
  • Trading above the 200-day average of 33.19

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 22.0 versus sector average of 34.7
  • Analyst targets imply +28.4% versus the current price
  • Revenue growth of +15.6%

Key Metrics & Analysis

Financial Health

Revenue Growth15.60%
Profit Margin11.17%
P/E Ratio22.0
ROE25.94%
ROA12.01%
Debt/Equity56.59
P/B Ratio6.1
Op. Cash Flow$327.7M
Free Cash Flow$262.3M
Industry P/E34.7

Technical Analysis

TrendBullish
RSI44.8
Support$34.33
Resistance$38.86
MA 20$35.97
MA 50$34.53
MA 200$33.19
MACDBearish
VolumeStable
Fear & Greed Index94.88

Valuation

Fair Value$38.01
Target Price$44.63
Upside/Downside28.42%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.00
Volatility26.05%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.